Shandong Xinhua Pharmaceutical Company Limited (XIN) — Financial Flexibility Index
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Financial Flexibility Index of 0.04x as of September 2023. Free cash flow of €136.81 Million (operating CF €56.11 Million minus capex €80.69 Million) represents 0% of total liabilities (€3.22 Billion). Check XIN total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shandong Xinhua Pharmaceutical Company Limited Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. For the full cash flow conversion analysis, see Shandong Xinhua Pharmaceutical Company L (XIN) cash flow conversion.
Annual Financial Flexibility Index for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Year-by-year free cash flow to debt coverage for Shandong Xinhua Pharmaceutical Company Limited. Explore Shandong Xinhua Pharmaceutical Company L debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | €649.33 Million | €533.73 Million | €3.73 Billion | ▲ +14.1% |
| 2024 | 0.15x | €580.03 Million | €367.61 Million | €3.80 Billion | ▼ -9.3% |
| 2023 | 0.17x | €590.41 Million | €265.28 Million | €3.51 Billion | ▼ -34.3% |
| 2022 | 0.26x | €1.00 Billion | €758.24 Million | €3.92 Billion | ▲ +85.5% |
| 2021 | 0.14x | €508.34 Million | €259.12 Million | €3.68 Billion | ▼ -27.0% |
| 2020 | 0.19x | €700.37 Million | €420.19 Million | €3.70 Billion | ▼ -12.0% |
| 2019 | 0.21x | €714.78 Million | €348.27 Million | €3.33 Billion | ▼ -5.9% |
| 2018 | 0.23x | €712.35 Million | €323.91 Million | €3.12 Billion | ▼ -5.5% |
| 2017 | 0.24x | €651.08 Million | €389.97 Million | €2.69 Billion | ▼ -4.1% |
| 2016 | 0.25x | €666.42 Million | €439.35 Million | €2.64 Billion | ▲ +22.1% |
| 2015 | 0.21x | €517.72 Million | €348.64 Million | €2.51 Billion | ▼ -20.6% |
| 2014 | 0.26x | €606.51 Million | €346.34 Million | €2.33 Billion | ▲ +23.0% |
| 2013 | 0.21x | €449.52 Million | €104.99 Million | €2.13 Billion | — |